Point Of Care Infection Control Market

Point Of Care Infection Control Market Overview

Inpatient admitted patients are often at risk of various infections such as hospital acquired pneumonia (HAP) and to avoid the infection aseptic conditions are required to be maintained. The incidence of the HAP is around 0.5 to 2% of all hospital admissions, the infection further increases complexity of treatment, disease management cost, etc.

Patients in which immune system is compromised are often at risk of the infection and in that scenario point of care infection control can play vital role for the prevention of the disease. It is reported that HAP affects 1 in every 1,000 discharges. Point of care infection control let’s limit or eliminate the infection lowering the risk of healthcare setting acquired infection. Infection could be from various sources but it is generally from the devices (equipment) used for operating the patient.

Point Of Care Infection Control Market: Drivers and Restraints

Increasing prevalence of the healthcare setting acquired infections such as HAP is expected to fuel the growth point of care infection control market. Increasing number of hospital or specialty clinic admission expected to further drive the growth of the point of care infection control market. Increased measures to limit the healthcare setting related infection further expected to propel the growth of point of care infection control market.

Increasing number of surgical procedures, respiratory diseases requiring oxygen therapy, etc. requires higher aseptic conditions, which in turn expected to drive the growth of point of care infection control market across the world. Need for the healthcare setting to keep up with the standard protocol of operating devices and other equipment conditions further expected to drive the growth of point of care infection control market.

Increasing expenditure by private players in the healthcare service providers sector further expected to drive the growth of point of care infection control market. Increasing awareness and understanding about the probable infections in inpatient setting further expected to drive the growth of point of care infection control market.

Whereas, limited awareness in developing countries about the point of care infection control may hamper the potential growth of the market.

Point Of Care Infection Control Market: Overview

The global point of care infection market expected to witness steady growth over the forecast period attributing to increasing use of point of care infection for sanitary conditions. By product type, germicidal wipes expected to be largest revenue generating segment in global point of care infection control market owing to higher adoption for sanitary condition maintenance.

By end user, hospitals expected to be the most lucrative segment in global point of care infection control owing to higher number of healthcare settings across the world. Manufacturers in the point of care infection control market are trying to manufacturer product with greater antiseptic index and easier to use formulation.

Point Of Care Infection Control Market: Regional Outlook

Global point of care infection control market is expected to be dominated by North America due to higher number of healthcare settings in the region. Latin America point of care infection control market is expected to witness steady growth over the forecast period due to increasing awareness about the possible hospital acquired infections.

Europe is expected to be the second most lucrative point of care infection control market owing to higher product availability. Asia-Pacific is regarded as the emerging point of care infection control market due to improving healthcare infrastructure in the region. MEA is expected to be the least lucrative region in the global point of care infection control market.

Point Of Care Infection Control Market: Key Players

Key players operating in the global point of care infection control are: 3M, TheraDoc, Stanley Healthcare, BioVigil, SW Safety Solutions, HyGreen, Global Life Technologies Corp., Magnolia Medical Technologies and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Indication
• Value Chain

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Point Of Care Infection Control Market: Segmentation

The global point of care infection control market is segmented on the basis of product type, end user and region.

By product type, the global point of care infection control market is segmented as:

• Germicidal Wipes
• Effervescent Disinfectant Sanitizer Tablets
• Hand Hygiene
• Others

By end user, the global point of care infection control market is segmented as:

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Surgery Centers